RenovoRx is developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents such as chemotherapy, to selected sites in the peripheral vascular system. Delivering these agents at a high concentration to specific vasculature – safely and without perfusion to other regions – is a central paradigm of our technology.
RenovoRx has developed the RenovoCath, which is FDA cleared and now being investigated in an active clinical trial to prove extended median survival and improved quality of life.
Management Team
Shaun R. Bagai
Chief Executive Officer
Ramtin Agah, MD
Chief Medical Officer, Founder
Kamran Najmabadi
Chief Technology Officer, Founder
Carole Ann McEvoy
Director of Clinical Operations
Imtiaz Qureshi, MD
Director of Imaging
Richard Taylor
Chief Financial Officer
Mary Hoxworth
Director of Marketing
Board of Directors
Shaun R. Bagai
Chief Executive Officer
Ramtin Agah, MD
Chief Medical Officer, Founder
Laurence J. Marton, MD
Director
Una S. Ryan, PhD, OBE
Director
Advisory Board
Jacob Cynamon, MD
Professor of Clinical Radiology, Albert Einstein College of Medicine Chief, Division of Vascular and Interventional Radiology
Program Director, Vascular and Interventional Radiology Fellowship Program Montefiore Medical Center, Bronx, NY
Mike Pishvaian, MD, PhD
Gastrointestinal Oncologist, Co-Director, Pancreatic Cancer Program at the Reusch Center, Phase
Program Director and Assistant Professor, Lombardi Comprehensive Cancer Center Georgetown University, Washington, D.C.
Peter Muscarella, MD
Director, Pancreatic Surgery General Surgery Site Director, Weiler Hospital
Associate Program Director, General Surgery Residency Training Program Montefiore Medical Center, Bronx, NY
Karyn A. Goodman, MD, MS
Professor of Radiation Oncology
Grohne Chair of Clinical Oncology
University of Colorado, Aurora, CO
Grohne Chair of Clinical Oncology
University of Colorado, Aurora, CO
Daniel D. Von Hoff, MD, FACP
Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute)
Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute
Clinical Professor of Medicine, University of Arizona, Tucson, AZ
Emmanuel Zervos, MD
Executive Director of Vidant Cancer Care Chief, Division of Surgical Oncology, East Carolina University Greenville, NC
Reza Malek, MD, MSc
Neurointerventional Radiologist, Minimally Invasive Surgical Solutions San Jose, CA
David C. Madoff, MD, FSIR, FACR
Professor of Radiology Vice Chairman of Academic Affairs Weill Cornell Medical College New York, NY